Adam Abramowitz

"Every deal is a unique and exciting journey. I fully commit myself in each process and seek to do justice to the passion and determination shown by our clients who have built world-class businesses."

Adam Abramowitz

Managing Director :: Co-Head of Healthcare

Education

  • Skidmore College, B.A. in Business and Economics, Magna Cum Laude

Professional Credentials

  • FINRA Registered General Securities Principal and Financial Principal
  • Board Member, Association for Corporate Growth (ACG) Los Angeles
  • Board of Directors for ACG LA
  • Board of Directors for JVS SoCal
  • Founder of ACG LA Rising Stars Program

Adam has more than 20 years of investment banking experience in the middle market. He joined Intrepid as Vice President and Founding Principal in 2010, after nearly a decade of focusing on middle-market mergers and acquisitions at Barrington Associates and Wells Fargo Securities. Adam has executed transactions involving private and public companies in a wide variety of industries, including consumer products, business services, healthcare, and industrial manufacturing. In addition to executing transactions, he’s actively involved in the management, growth, and development of the firm.

While Adam began his investment career working across a broad range of industries, for the past few years, he has helped to build and grow Intrepid’s Healthcare Group to one of the most active in the Western U.S. Today, Adam advises companies in the physician practice management, life sciences, and behavioral healthcare spaces working with dynamic entrepreneurs. Recently, the Los Angeles Business Journal named Adam the “Healthcare Trusted Advisor of the Year” and a “Leader of Influence in Investment Banking.”

Some of his notable recent transactions include the sale of Apostrophe, a leading teledermatology platform, on its sale to Hims & Hers Health, Inc. (NYSE: HIMS), a leading multi-specialty telehealth platform, which became a public company via a SPAC in early 2021. Adam led the sale of Mosaic Laboratories, a specialized bioanalytical lab serving pharma companies in their clinical trials research, to CellCarta, a portfolio company of Arsenal Capital. Moreover, Adam helped lead the groundbreaking sale of Ambry Genetics to Konica Minolta in a deal valued at $1 billion. Adam is highly regarded among his clients and peers for the tenacity with which he approaches deals and his proactivity to bring creative solutions to challenging deals.

Since 2016, Adam has served on the Board of Directors for ACG Los Angeles Chapter. In particular, he has a passion for helping young professionals build their careers. In 2012, Adam created and spearheaded the launch of the ACG Rising Stars Program. This has been one of ACG’s most successful programs that has been oversubscribed with participants. In June 2021, Adam was awarded the JVS SoCal Generation Impact Award and in 2019 he was selected as Vice Chair of the Emerging Leaders Program for JVS SoCal as he also serves on its Board of Directors. Adam has a passion for helping those who need assistance to find and develop critical skills to gain meaningful employment.

Adam is a passionate Washington professional football fan who remains loyal, despite the team’s challenges on the field. On his daily run each morning, he enjoys listening to various sports and entertainment podcasts.

Featured Transactions

*Represents transactions executed by principals of Intrepid while at prior firms.